Index of artpub/2025/321753/

Jiménez-Vicente, Carlos
Allo-HCT refined ELN 2022 risk classification : validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
2025
https://ddd.uab.cat/record/321753